MACROGENICS, INC. Increase (Decrease) in Accrued Liabilities
MACROGENICS, INC. (MGNX) reported Increase (Decrease) in Accrued Liabilities of $7.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- MACROGENICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $11.10M.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$3.72M.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$921.00K, a 121.15% decline year-over-year.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $1.74M, a 777.78% increase year-over-year.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$6.83M, a 236.60% decline from fiscal 2024.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $5.00M.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$4.82M.
- MACROGENICS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$4.64M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $7.38M 10-Q · filed 2026-08-14 | $6.46M derived: sum of 3 quarters · filed 2026-08-14 | $8.20M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$3.72M 10-Q · filed 2026-05-13 | -$4.64M derived: sum of 2 quarters · filed 2026-05-13 | -$2.90M derived: sum of 3 quarters · filed 2026-05-13 | -$9.39M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$921.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $817.00K derived: sum of 2 quarters · filed 2026-03-09 | -$5.67M derived: sum of 3 quarters · filed 2026-08-14 | -$6.83M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.75M derived: sum of 2 quarters · filed 2026-08-14 | -$5.91M 10-Q · filed 2025-11-12 | -$1.56M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$6.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$7.65M 10-Q · filed 2026-08-14 | -$3.30M derived: sum of 3 quarters · filed 2026-08-14 | -$3.10M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$1.16M 10-Q · filed 2026-05-13 | $3.19M derived: sum of 2 quarters · filed 2026-05-13 | $3.39M derived: sum of 3 quarters · filed 2026-05-13 | $9.73M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $4.55M derived: sum of 2 quarters · filed 2026-03-09 | $10.89M derived: sum of 3 quarters · filed 2026-03-09 | $5.00M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $6.54M derived: sum of 2 quarters · filed 2025-11-12 | $648.00K 10-Q · filed 2025-11-12 | -$787.00K derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-06-30 | $6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $450.00K 10-Q · filed 2025-08-14 | -$985.00K derived: sum of 3 quarters · filed 2026-03-09 | -$3.08M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-03-31 | -$5.89M 10-Q · filed 2025-05-13 | -$7.33M derived: sum of 2 quarters · filed 2026-03-09 | -$9.42M derived: sum of 3 quarters · filed 2026-03-09 | -$10.04M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2023-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$3.53M derived: sum of 2 quarters · filed 2026-03-09 | -$4.15M derived: sum of 3 quarters · filed 2026-03-09 | -$4.82M 10-K · filed 2026-03-09 | |||
| 2023-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$2.71M derived: sum of 2 quarters · filed 2024-11-05 | -$3.39M 10-Q · filed 2024-11-05 | -$7.84M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-06-30 | -$616.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.29M 10-Q · filed 2024-08-06 | -$5.75M derived: sum of 3 quarters · filed 2025-03-20 | -$4.23M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-03-31 | -$677.00K 10-Q · filed 2024-05-09 | -$5.13M derived: sum of 2 quarters · filed 2025-03-20 | -$3.62M derived: sum of 3 quarters · filed 2025-03-20 | -$4.77M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2022-12-31 | -$4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$2.94M derived: sum of 2 quarters · filed 2025-03-20 | -$4.09M derived: sum of 3 quarters · filed 2025-03-20 | -$4.64M 10-K · filed 2025-03-20 | |||
| 2022-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $359.00K derived: sum of 2 quarters · filed 2023-11-06 | -$184.00K 10-Q · filed 2023-11-06 | -$8.54M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.70M 10-Q · filed 2023-08-09 | -$10.05M derived: sum of 3 quarters · filed 2024-03-07 | -$7.67M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-03-31 | -$543.00K 10-Q · filed 2023-05-09 | -$8.89M derived: sum of 2 quarters · filed 2024-03-07 | -$6.51M derived: sum of 3 quarters · filed 2024-03-07 | -$2.00M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2021-12-31 | -$8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$5.97M derived: sum of 2 quarters · filed 2024-03-07 | -$1.46M derived: sum of 3 quarters · filed 2024-03-07 | -$607.00K 10-K · filed 2024-03-07 | |||
| 2021-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $6.89M derived: sum of 2 quarters · filed 2022-11-03 | $7.74M 10-Q · filed 2022-11-03 | $9.24M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2021-06-30 | $4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.37M 10-Q · filed 2022-08-08 | $6.86M derived: sum of 3 quarters · filed 2023-03-15 | $9.02M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2021-03-31 | $855.00K 10-Q · filed 2022-05-03 | $2.35M derived: sum of 2 quarters · filed 2023-03-15 | $4.51M derived: sum of 3 quarters · filed 2023-03-15 | $9.97M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.66M derived: sum of 2 quarters · filed 2023-03-15 | $9.11M derived: sum of 3 quarters · filed 2023-03-15 | $6.99M 10-K · filed 2023-03-15 | |||
| 2020-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $7.62M derived: sum of 2 quarters · filed 2021-11-02 | $5.50M 10-Q · filed 2021-11-02 | $4.12M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $5.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $3.34M 10-Q · filed 2021-07-29 | $1.96M derived: sum of 3 quarters · filed 2022-02-24 | -$57.00K derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$2.12M 10-Q · filed 2021-04-29 | -$3.50M derived: sum of 2 quarters · filed 2022-02-24 | -$5.51M derived: sum of 3 quarters · filed 2022-02-24 | -$3.88M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$3.39M derived: sum of 2 quarters · filed 2022-02-24 | -$1.76M derived: sum of 3 quarters · filed 2022-02-24 | -$6.06M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$381.00K derived: sum of 2 quarters · filed 2020-11-04 | -$4.68M 10-Q · filed 2020-11-04 | -$10.93M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$2.66M 10-Q · filed 2020-07-31 | -$8.91M derived: sum of 3 quarters · filed 2021-02-25 | -$7.67M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$4.30M 10-Q · filed 2020-05-05 | -$10.55M derived: sum of 2 quarters · filed 2021-02-25 | -$9.30M derived: sum of 3 quarters · filed 2021-02-25 | -$2.57M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$5.01M derived: sum of 2 quarters · filed 2021-02-25 | $1.73M derived: sum of 3 quarters · filed 2021-02-25 | $3.21M 10-K · filed 2021-02-25 | $3.51M 10-K · filed 2019-02-26 | ||
| 2018-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $7.98M derived: sum of 2 quarters · filed 2019-11-06 | $9.46M 10-Q · filed 2019-11-06 | $12.79M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $6.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $8.21M 10-Q · filed 2019-07-31 | $11.55M derived: sum of 3 quarters · filed 2020-02-25 | $14.86M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $1.48M 10-Q · filed 2019-05-01 | $4.81M derived: sum of 2 quarters · filed 2020-02-25 | $8.12M derived: sum of 3 quarters · filed 2020-02-25 | $12.49M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.65M derived: sum of 2 quarters · filed 2020-02-25 | $11.01M derived: sum of 3 quarters · filed 2020-02-25 | $12.83M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $7.68M derived: sum of 2 quarters · filed 2018-11-07 | $9.50M 10-Q · filed 2018-11-07 | $10.27M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.18M 10-Q · filed 2018-08-07 | $6.95M derived: sum of 3 quarters · filed 2019-02-26 | $9.98M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $1.82M 10-Q · filed 2018-05-07 | $2.59M derived: sum of 2 quarters · filed 2019-02-26 | $5.62M derived: sum of 3 quarters · filed 2019-02-26 | $8.27M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.79M derived: sum of 2 quarters · filed 2019-02-26 | $6.45M derived: sum of 3 quarters · filed 2019-02-26 | $4.66M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $5.68M derived: sum of 2 quarters · filed 2017-11-08 | $3.90M 10-Q · filed 2017-11-08 | $6.25M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $866.00K 10-Q · filed 2017-08-02 | $3.22M derived: sum of 3 quarters · filed 2018-02-27 | $4.04M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | -$1.79M 10-Q · filed 2017-05-03 | $567.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.38M derived: sum of 3 quarters · filed 2018-02-27 | $2.69M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.17M derived: sum of 2 quarters · filed 2018-02-27 | $4.47M derived: sum of 3 quarters · filed 2018-02-27 | $3.54M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $815.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $2.12M derived: sum of 2 quarters · filed 2016-11-02 | $1.19M 10-Q · filed 2016-11-02 | $5.09M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $375.00K 10-Q · filed 2016-08-03 | $4.27M derived: sum of 3 quarters · filed 2017-02-28 | $5.00M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | -$929.00K 10-Q · filed 2016-05-04 | $2.97M derived: sum of 2 quarters · filed 2017-02-28 | $3.69M derived: sum of 3 quarters · filed 2017-02-28 | $4.26M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $4.62M derived: sum of 2 quarters · filed 2017-02-28 | $5.19M derived: sum of 3 quarters · filed 2017-02-28 | $4.35M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $721.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.29M derived: sum of 2 quarters · filed 2015-11-04 | $447.00K 10-Q · filed 2015-11-04 | $3.09M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $574.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$274.00K 10-Q · filed 2015-08-05 | $2.37M derived: sum of 3 quarters · filed 2016-02-29 | $2.37M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$848.00K 10-Q · filed 2015-05-06 | -$848.40K 10-Q · filed 2014-05-06 | $1.80M derived: sum of 2 quarters · filed 2016-02-29 | $1.79M derived: sum of 3 quarters · filed 2016-02-29 | $1.47M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.64M derived: sum of 2 quarters · filed 2016-02-29 | $2.32M derived: sum of 3 quarters · filed 2016-02-29 | $2.35M 10-K · filed 2016-02-29 | $2.35M 10-K · filed 2014-03-20 | ||
| 2013-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$321.31K derived: sum of 2 quarters · filed 2014-11-12 | -$297.00K 10-Q · filed 2014-11-12 | -$297.21K 10-Q · filed 2013-11-12 | -$165.86K derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | -$320.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$296.00K 10-Q · filed 2014-08-05 | -$164.86K derived: sum of 3 quarters · filed 2015-03-03 | ||||
| 2013-03-31 | $24.32K 10-Q · filed 2014-05-06 | $155.46K derived: sum of 2 quarters · filed 2015-03-03 | |||||
| 2012-12-31 | $131.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $185.00K 10-K · filed 2015-03-03 | $185.20K 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | $53.86K 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | $272.99K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |